TrueMark STI Select Panel

The global prevalence of sexually transmitted infections (STIs) is measured at more than 1 million new cases every day, most of which are asymptomatic. Accordingly, there are approximately 374 million new infections each year, which include three of the most common curable STIs: chlamydia, gonorrhea, and
trichomoniasis [1]. These three STIs, as well as the bacterium Mycoplasma genitalium, can lead to complications including cervicitis, urethritis, preterm labor, and pelvic inflammatory
disease (PID). They can also increase the risk of contracting HIV.

This makes the detection of common prevalent STIs important for clinical researchers to understand outbreaks and disease etiology

The Applied Biosystems™ TrueMark™ STI Select Panel employs real-time PCR technology, offering an end-to-end workflow for the detection of common STIs by utilizing the power of Applied Biosystems™ QuantStudio™ real-time PCR
(qPCR) systems.*

The TrueMark STI Select Panel includes multiplexed assays in a single-tube format to detect Chlamydia trachomatis, Neisseria
gonorrhea, Mycoplasma genitalium, and Trichomonas vaginalis, as well as internal process control, in the same reaction. QuantStudio real-time PCR systems enable rapid, accurate detection and categorization of these microorganisms
that cause four common STIs.